Nursing Considerations for CDK4/6 Inhibitors in HR+/HER2- Breast Cancer
Nursing Considerations for CDK4/6 Inhibitors in HR+/HER2- Breast Cancer

Released: June 30, 2022

Expiration: June 29, 2023

Julia A LaBarbera
Julia A LaBarbera, MSN, RN, AGACNP-BC

Activity

Progress
1
Course Completed